| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |